Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
16.09.2025
A new study with support from the German Center for Infection Research (DZIF) warns of the dawn of an extensively drug-resistant tuberculosis (XDR-TB) epidemic in Europe, threatening to leave physicians without effective medicines in the treatment of tuberculosis. Conducted in the Republic of Moldova, one of the world’s highest-burden countries with drug-resistant tuberculosis, this is the first nationwide evidence in the northern hemisphere of resistan
04.09.2025
With the enrollment of the first patient, the PerMed-COPD study has now officially started at the Research Center Borstel, Leibniz Lung Center.
19.08.2025
Am 18. August 2025 besuchte die Finanzministerin des Landes Schleswig-Holstein, Dr. Silke Schneider, das Forschungszentrum Borstel, Leibniz Lungenzentrum. Begleitet von Claudia Prehn und Jannah Linz aus dem Finanzministerium informierte sie sich im Rahmen ihrer Sommertour über die aktuellen Forschungsprojekte und erhielt Einblicke in die fortlaufende Modernisierung und Weiterentwicklung der Forschungsinfrastruktur auf dem Borsteler Campus.